Carmell Therapeutics Closes $4MM Series B Funding
Carmell Therapeutics closed a US $4MM Series B financing. Funds will support Phase III clinical development of the company’s Bone Healing Accelerant product. Jul 11, 2017
SeaSpine Reports Preliminary 2Q17 Revenue
SeaSpine announced preliminary 2Q17 revenue in the range of US $34.0MM to $34.2MM, +3% vs. 2Q16. Jul 11, 2017
K2M Enters Distribution Agreement with Japan Medicalnext
K2M signed a long-term exclusive distribution agreement with Japan Medicalnext. Jul 11, 2017
Study Results: Providence Medical’s CAVUX and DTRAX Fusion Technologies
Studies indicate that Providence Medical Technology’s tissue-sparing cervical fusion devices, CAVUX® Cervical and DTRAX® Expandable cages, yielded improvements in pain, with radiographic confirmation of fusion. Jul 10, 2017
Medtronic Recalls Kyphon Directional Bone Void Filler Device
Medtronic is recalling its KYPHON® Directional Bone Void Filler due to a misalignment issue that may cause injected cement to be placed in an unintended direction. Jul 10, 2017
Amendia Rebrands as Spinal Elements
Amendia is changing its name to Spinal Elements, reflecting the transaction that combined the companies in early 2Q17. Jul 10, 2017
Full Commercial Launch for SeaSpine’s Mariner Posterior Fixation
SeaSpine commenced full launch of the Mariner® pedicle-based system for posterior spinal fixation. Jul 07, 2017
Ortho Development Signs Agreement for China Distribution of Balanced Knee
Ortho Development granted China Pioneer Pharma exclusive regional distribution rights for the Balanced Knee® system. Jul 06, 2017
Regulatory Clearances for K2M’s NILE Proximal Fixation System
K2M received FDA 510(k) clearance and approval under the CE Mark for the NILE® Proximal Fixation system to treat complex spinal deformity. Jul 06, 2017
Clinical Trial of Stem Cells to Treat Massive Knee Cartilage Injury
A 6-year, randomized clinical trial is underway to evaluate use of a patient’s own stem cells to regenerate knee cartilage. Jul 06, 2017
